Literature DB >> 3740157

Acute myocardial infarction in the puerperium in patients receiving bromocriptine.

L Iffy, W TenHove, G Frisoli.   

Abstract

Although described in the literature as a powerful vasodilator, bromocriptine has been noted to cause vasospasm and hypertension. Two cases are presented where administration of bromocriptine in the puerperium was associated with massive myocardial infarction. These incidents suggest the possibility that bromocriptine occasionally displays the vasoconstrictor effects of other (nonhydrogenated) ergot alkaloids.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3740157     DOI: 10.1016/0002-9378(86)90829-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

Review 1.  Therapeutic applications of bromocriptine in endocrine and neurological diseases.

Authors:  K Y Ho; M O Thorner
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

2.  Ischaemic heart disease in pregnancy.

Authors:  Nabeel S Bondagji
Journal:  J Saudi Heart Assoc       Date:  2012-01-20

3.  Bromocriptine and suppression of postpartum lactation. The incidence of adverse cardiovascular effects in women of child-bearing age.

Authors:  R M Herings; B H Stricker
Journal:  Pharm World Sci       Date:  1995-07-28

4.  Dopamine agonists and ischemic complications in Parkinson's disease: a nested case-control study.

Authors:  Maurits E L Arbouw; Kris L L Movig; Henk-Jan Guchelaar; Cees Neef; Toine C G Egberts
Journal:  Eur J Clin Pharmacol       Date:  2011-07-22       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.